Skip to main content
. 2019 Nov 26;2019(11):CD009286. doi: 10.1002/14651858.CD009286.pub3

Jia 2005.

Methods Parallel design
Aim: to determine the effect of early intervention for post stroke depression on movement after 3 months of stroke
Participants Country: China
Setting: inpatient
Inclusion: aged 40 to 75 years, all pathological types of stroke, clinical diagnosis plus confirmation by imaging (did not state whether a relevant lesion had to be present to make a diagnosis), able to give informed consent
Depression diagnosis: Zung SDS > 41 for screening for depression, HDRS for evaluation of the depression severity level
Treatment: 92 people randomised, 90 accepted allocation, mean age 55.6 ± 6.5 years, 60 men
Control: 92 people randomised, 90 accepted allocation, mean age 55.1 ± 6.8, 55 men
Excluded: organic psychiatric disorders such as Alzheimer's disease or degenerative disease, functional disorders such as schizophrenia and affective disorders
Interventions Treatment: either fluoxetine or sertraline (given sertraline if also had anxiety) plus routine stroke care
Control: routine stroke care
Duration of treatment: 3 months
Duration of follow‐up: 3 years but the authors did not describe the extent of neurological function damage and HAMD scores in the third year
Outcomes HAMD
Extent of neurological damage
Recurrent stroke
Death
Did not report AEs
Funding source Source of funding not stated
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) 
 All outcomes High risk No placebo
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No blinding
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Dropouts: 6 in treatment group (2 refused allocation), 4 in control group (2 refused allocation)
Selective reporting (reporting bias) Unclear risk No protocol
Other bias Unclear risk Balanced baseline